'Pediatric research equity act' presentation slideshows

Drugs for children

970 views • 66 slides

FDA OVERVIEW: Protecting Consumers - Promoting Public Health

FDA OVERVIEW: Protecting Consumers - Promoting Public Health. Frieda Houghton PhD Worldwide Regulatory Strategy Pfizer June 2013. TODAY.

775 views • 59 slides

Training Workshop on Pharmaceutical Development with focus on Paediatric Formulations Protea Hotel Victoria Junction, Wa

Regulatory requirements for the development of medicinal products for pediatric use. Training Workshop on Pharmaceutical Development with focus on Paediatric Formulations Protea Hotel Victoria Junction, Waterfront Cape Town, South Africa Date: 16 to 20 April 2007.

746 views • 50 slides

Labels A Century Ago 918 . Source: www.wellcomecollection.org

Ethical, Social , and Good Clinical Practice (GCP) A spects O f D rug D evelopment In Children A nd In Paediatric C linical T rials Klaus Rose, klausrose Consulting Pediatric Drug Development & More klaus.rose@klausrose.net. Labels A Century Ago 918 .

605 views • 38 slides

588 views • 33 slides

511 views • 31 slides

472 views • 27 slides

The Ethical Conduct of Clinical Research Involving Children Institute of Medicine

The Ethical Conduct of Clinical Research Involving Children Institute of Medicine National Academy of Sciences 2004. IOM/Academies Reports. Ethical Conduct of Clinical Research Involving Children (2004) Responsible Research (2003)

389 views • 22 slides

The Best Pharmaceuticals for Children Act

The Best Pharmaceuticals for Children Act. Anne Zajicek, M.D., Pharm.D. Pediatric Medical Officer National Institute of Child Health and Human Development National Institutes of Health. Best Pharmaceuticals for Children Act.

367 views • 21 slides

Overview and Regulatory Issues Regarding Anesthetic Agents for Pediatric Patients

Overview and Regulatory Issues Regarding Anesthetic Agents for Pediatric Patients. Anesthetics and Life Support Drugs Advisory Committee Meeting March 29, 2007 Arthur Simone, MD, PhD Division of Anesthesia, Analgesia and Rheumatology Products. Center for Drug Evaluation and Research.

372 views • 21 slides

Endpoints for Pediatric Brain Tumors December 6, 2006 meeting of the Pediatric Subcommittee to ODAC

Endpoints for Pediatric Brain Tumors December 6, 2006 meeting of the Pediatric Subcommittee to ODAC. Karen D. Weiss, M.D. Deputy Director Office of Oncology Drug Products. Pediatric Brain Tumors. Pediatric Oncology. General Pediatrics. General Oncology. General Pediatrics.

464 views • 20 slides

The Risks of Cough/Cold Preparations to Young Children

331 views • 19 slides

Chapter 10

Chapter 10. Drug Therapy in Pediatric Patients. Pediatric Patients. All patients younger than16 years Respond differently to drugs than the rest of the population More sensitive to drugs than other patients are Show greater individual variation

327 views • 18 slides

1.15k views • 14 slides

Overview of Pediatric Drug Development

Overview of Pediatric Drug Development. Dianne Murphy, MD Director Office of Counterterrorism and Pediatric Drug Development Center for Drug Evaluation and Research February 2, 2004. Goals.

1.14k views • 14 slides